Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
11.06
+0.04 (0.32%)
Jul 28, 2026, 4:00 PM EDT - Market closed
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $667.59 million as of July 28, 2026. Its market cap has decreased by -30.88% in one year.
Market Cap
667.59M
Enterprise Value
393.58M
1-Year Change
-30.88%
Ranking
Category
Stock Price
$11.06
ChartMarket Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $667.59M, an increase of 319.69%. That is a compound annual growth rate of 31.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 667.59M | -42.17% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 729.78M |
| Candel Therapeutics | 726.11M |
| Crescent Biopharma | 723.17M |
| Replimune Group | 708.66M |
| Neurogene | 708.25M |
| Rigel Pharmaceuticals | 705.30M |
| Bright Minds Biosciences | 697.64M |
| SpyGlass Pharma | 697.09M |